Skip to Main Content

Paper Details

Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
Proc Natl Acad Sci U S A
117
2012
AKT, CYT-1, ErbB4, ErbB4 receptor, IC87114, NRG1, Neuregulin, Neuregulin 1, PI(3,4,5)P3, PI3K, PIK3CD, amphetamine, human, human lymphoblasts, mice, mouse, neonatal, neurodevelopmental genes, p110, patients, phosphatidyl-inositol,3,4,5 triphosphate, phosphoinositide 3-kinase, phosphoinositide 3-kinase subunit, psychiatric disorders, psychosis, rat, schizophrenia, ventral hippocampal lesion

Datasets

Release 1.2